Lincoln Pharmaceuticals
618.50
-0.55(-0.09%)
Market Cap₹1,238.84 Cr
PE Ratio14.10
IndustryHealthcare
Company Performance:
1D-0.09%
1M+33.01%
6M+11.22%
1Y+14.22%
5Y+161.03%
View Company Insightsright
More news about Lincoln Pharmaceuticals
02Jul 25
Lincoln Pharmaceuticals Completes Trial Run at Khatraj Facility, Eyes API Production
Lincoln Pharmaceuticals has successfully completed the trial run of its Khatraj facility, a key step in its expansion plans. The company aims to commence commercial production of Active Pharmaceutical Ingredients (APIs) at this facility within 1-2 years, subject to regulatory approvals. This move is expected to enhance manufacturing capabilities, potentially leading to vertical integration, cost efficiency, improved quality control, and stronger market positioning.
 no imag found
Lincoln Pharmaceuticals
618.50
-0.55
(-0.09%)
1 Year Returns:+14.22%
Industry Peers
Sun Pharmaceutical
1,750.50
(-0.11%)
Divis Laboratories
6,316.00
(-1.37%)
Torrent Pharmaceuticals
4,341.00
(-0.65%)
Dr Reddys Laboratories
1,291.20
(-0.25%)
Cipla
1,313.20
(-2.84%)
Lupin
2,304.90
(-0.27%)
Mankind Pharma
2,207.20
(-1.71%)
Zydus Life Science
896.90
(-1.10%)
Aurobindo Pharma
1,195.40
(-1.24%)
Alkem Laboratories
5,466.50
(-1.79%)